Cause Areas


It's flexible! We'll work with your schedule.


740 Westwood PlazaLos Angeles, CA 90024


For those who are suffering from feelings of depression, sadness, hopelessness, memory loss, concentration difficulties, lack of energy, or loss of interest and pleasure in activities; UCLA is conducting a 12-week research study comparing levomilnacipran (FETZIMA) to placebo for treatment of geriatric depression. If you are 60 years of age or older, you may qualify. A complete psychiatric evaluation, physical exam, and two MRI scans are provided as a part of the study. All participants will be given either levomilnacipran (FETZIMA) or a placebo (an inactive substance). You will be compensated up to $200 and parking will be reimbursed.

Compensation is available! We offer $350 + parking

Study Site Contact Phone: (310) 267-5264

Study Site Contact Email:


Good Match For


Requirements & Commitment

  • Must be at least 60

Report this opportunity

Report this opportunity